Challenges of using natriuretic peptides to screen for the risk of developing heart failure in patients with diabetes: a report from the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Clinical Applications of Cardiac Bio-Markers (C-CB)Allan S Jaffeon August 11, 2025 at 10:00 am
Clin Chem Lab Med. 2025 Aug 12. doi: 10.1515/cclm-2025-0863. Online ahead of print. ABSTRACT BACKGROUND: Several guidelines groups have made recommendations about how to use natriuretic peptides (NPs) to screen patients with diabetes for incipient heart failure. This group is at risk for undetected and stage B heart failure, where structural heart disease is present … Read more
